Anaphylaxis: Clinical Trials

95 trials for Anaphylaxis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

56 completed, 15 recruiting, 13 unknown, 4 terminated. 18 Not applicable, 15 Phase 1, 9 Phase 2, 7 Phase 4, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable18Completed 14, Active not recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 115Completed 12, Enrolling by invitation 1, Recruiting 1, Unknown 1
Phase 29Completed 5, Recruiting 2, Enrolling by invitation 1, Unknown 1
Phase 47Completed 4, Terminated 2, Recruiting 1
Phase 33Completed 1, Recruiting 1, Terminated 1

Follow Anaphylaxis: new trials by email Literature Review of Anaphylaxis trials Research Report on Anaphylaxis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FASC: Fish Allergy in Spanish Children - A Study of New Cases of Fish Allergy in Children and Adolescents
Fish Allergy, Food Hypersensitivity
Not yet recruitingCarmelo Escudero1202026-10-012026-07-27
Post-market Safety Study of LUMISIGHT
Hypersensitivity Reactions
RecruitingLumicell, Inc.15002026-09-302026-10-14
Virtual Reality-Based Simulation Versus High-Fidelity Simulation for Emergency Management Training in Medical Interns
Virtual Reality-Based Emergency Simulation, High-Fidelity Simulation - Anaphylaxis, Hypoxia
Not applicableActive not recruitingSeoul National University Hospital1242026-02-202026-05-13
Steroid Use in Treatment of Allergic Reactions to Food
Antihistamines, Systemic corticosteroids, Adrenaline (rescue medication) - Anaphylactic Reaction, Anaphylaxis
Phase 4RecruitingJohannes Trueck1602026-01-262026-01-27
Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
FMXIN002 single dose, Epinephrine autoinjector single dose, FMXIN002 single dose + NAC - Anaphylaxis, Allergy
Phase 1 / Phase 2Enrolling by invitationNasus Pharma502025-11-032025-11-14
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray - Food Allergy, Anaphylaxis
Phase 1CompletedInsignis Therapeutics, Inc.322025-10-242026-05-05
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges
Inhaled Epinephrine - Hypersensitivity, Anaphylaxis
Phase 1RecruitingDr. George Luciuk1002025-08-252026-08-10
Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study
"Rush" regimen, "Conventional" regimen - Food Allergy in Children, Milk Allergy
Phase 2 / Phase 3RecruitingPablo Rodríguez del Rio402025-06-032026-02-18
Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers
KP001, Placebo - Acute Allergic Reaction, Anaphylaxis
Phase 1CompletedKokua Pharma Inc.162025-05-092025-08-27
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-09-04
Diagnosis and Allergen Identification of Perioperative Anaphylaxis
Perioperative/Postoperative Complications, Anaphylaxis
RecruitingPeking University First Hospital1152025-01-252026-06-18
Analysis of the Role of IgE Proteoforms in Health and Disease
Blood sample collection - Anaphylaxis, Mastocytosis
RecruitingKU Leuven2002025-01-012026-01-09
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges
Inhaled Epinephrine - Hypersensitivity, Anaphylaxis
Phase 1CompletedDr. George Luciuk212024-07-152025-07-25
Tolerance in Beekeepers
skin prick test, Blood tests - Bee Sting
RecruitingUniversity Hospital Plymouth NHS Trust1202024-01-222026-09-17
Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.
Epinephrine, Placebo - Anaphylactic Reaction
Phase 1CompletedDe Motu Cordis242023-10-242024-08-20
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
Full dose DPT with propofol, Full dose DPT with ketamine, Full dose DPT with etomidate - Allergic Reaction, Hypersensitivity
Not applicableCompletedUniversity Hospital, Antwerp502023-10-232025-09-08
Comparative Bioavailability of Intranasal Epinephrine
A: Epinephrine injection, B: FMXIN002 3.6mg, C: FMXIN002 4.0mg - Anaphylaxis, Anaphylactic Reaction
Phase 1 / Phase 2CompletedNasus Pharma122023-08-222025-06-18
INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions
Salbutamol, Placebo - IgE-mediated Abdominal Pain
Phase 3TerminatedPhilippe Bégin242023-07-012025-05-21
A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis
Food Hypersensitivity, Anaphylaxis
CompletedNovartis Pharmaceuticals622023-06-012025-06-18
Design, Implementation and Evaluation of the Guided Observer Role in Clinical Simulation
Educational intervention. observation guide - Anaphylactic Reaction
Not applicableCompletedClinica Universidad de Navarra, Universidad de Navarra1232023-05-102024-05-08

Showing 20 of 95. Sign in to see all of them.

Narrower conditions

Hypersensitivity (30)  ·  Food Hypersensitivity (22)  ·  Peanut Hypersensitivity (12)  ·  Drug Hypersensitivity (7)  ·  Hypersensitivity, Immediate (6)  ·  Asthma (4)  ·  Egg Hypersensitivity (4)  ·  Mastocytosis (4)  ·  Emergencies (3)  ·  Hypotension (3)  ·  Milk Hypersensitivity (3)  ·  Nut Hypersensitivity (3)  ·  Angioedema (2)  ·  Bronchial Spasm (2)

Broader conditions

Immune System Diseases (94)  ·  Hypersensitivity, Immediate (89)  ·  Hypersensitivity (65)  ·  Nut and Peanut Hypersensitivity (12)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Chemically-Induced Disorders (10)  ·  Respiratory Tract Diseases (10)  ·  Skin and Connective Tissue Diseases (10)  ·  Skin Diseases (9)  ·  Pathologic Processes (8)  ·  Drug-Related Side Effects and Adverse Reactions (7)  ·  Bronchial Diseases (6)  ·  Lung Diseases (6)  ·  Signs and Symptoms (6)  ·  Cardiovascular Diseases (5)

Interventions

Epinephrine (11)  ·  Omalizumab (4)  ·  Albuterol (2)  ·  Inhalation (2)  ·  Milk (2)  ·  2019-nCoV Vaccine mRNA-1273 (1)  ·  Acetaminophen (1)  ·  Allergens (1)  ·  Amoxicillin (1)  ·  Ampicillin (1)  ·  Basophil Degranulation Test (1)  ·  Betamethasone (1)  ·  Blood Specimen Collection (1)  ·  COVID-19 Vaccines (1)  ·  Cefaclor (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (5)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Central Hospital, Nancy, France (3)  ·  Nasus Pharma (3)  ·  University Hospital, Montpellier (3)  ·  Cambridge University Hospitals NHS Foundation Trust (2)  ·  Charite University, Berlin, Germany (2)  ·  De Motu Cordis (2)  ·  Dr. George Luciuk (2)  ·  Imperial College London (2)  ·  University Hospital, Strasbourg, France (2)  ·  Zhong Wang (2)  ·  Adan Medical Innovation, SL (1)  ·  Algemeen Ziekenhuis Maria Middelares (1)  ·  Amphastar Pharmaceuticals, Inc. (1)

Countries

United States (21)  ·  France (17)  ·  Canada (9)  ·  United Kingdom (7)  ·  Australia (4)  ·  Belgium (4)  ·  China (4)  ·  Germany (4)  ·  Spain (3)  ·  Finland (2)  ·  Israel (2)  ·  Italy (2)  ·  Thailand (2)  ·  Turkey (Türkiye) (2)  ·  Austria (1)

Top investigators

George H. Luciuk, MD (2)  ·  Pamela A Frischmeyer-Guerrerio, M.D. (2)  ·  Paul J Turner, FRACP PhD (2)  ·  Zhong Wang, M.D. (2)  ·  Abdelkader Rahmaoui, M.D. (1)  ·  Amy C Plint, MD (1)  ·  Andrew T Clark, MB BD MD (1)  ·  Andrew T Clark, MB BS MD (1)  ·  Arzu Bakirtas (1)  ·  Aurelie Gouel, MD, PhD (1)  ·  Ayca Kiykim (1)

Results publications

PMID 11061773, PMID 11692118, PMID 12960536, PMID 16461140, PMID 17225722, PMID 18005384, PMID 19226304, PMID 19486033, PMID 19927537, PMID 20004784, PMID 20143649, PMID 21414048, PMID 21749463, PMID 23174658, PMID 23667834, PMID 24239340, PMID 24725226, PMID 24811018, PMID 24811020, PMID 24813248, PMID 25070464, PMID 25215127, PMID 25684279, PMID 25705822, PMID 25705823, PMID 25820033, PMID 26032476, PMID 26095285, PMID 26112147, PMID 26276313, PMID 27297994, PMID 27643438, PMID 28069483, PMID 28884986, PMID 28888253, PMID 28956131, PMID 29040433, PMID 29449164, PMID 29615480, PMID 29759531, PMID 29930853, PMID 30236237, PMID 30288817, PMID 30730977, PMID 30763927, PMID 31035000, PMID 31319102, PMID 31642933, PMID 31676085, PMID 31704438

NIH funding

2017 (2), U01AI184071 (1)